149 related articles for article (PubMed ID: 29953803)
1. Advanced stage yolk sac ovarian tumour: clinical approach with cytoreductive surgery upfront.
Pimentel I; González Martin A; Bratos R; Marquez R; Toledo G; Chiva L
Eur J Gynaecol Oncol; 2017; 38(2):311-313. PubMed ID: 29953803
[TBL] [Abstract][Full Text] [Related]
2. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
3. Primary yolk sac tumor of the omentum: a case report and review of the literature.
Kim SW; Park JH; Lim MC; Park JY; Yoo CW; Park SY
Arch Gynecol Obstet; 2009 Feb; 279(2):189-92. PubMed ID: 18648830
[TBL] [Abstract][Full Text] [Related]
4. Primary yolk sac tumor of the omentum: a case report and literature review.
Haibin Z; Yue J; Yaxian X
Eur J Gynaecol Oncol; 2010; 31(6):682-4. PubMed ID: 21319517
[TBL] [Abstract][Full Text] [Related]
5. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience.
Zhang GY; Zhang R; Wu LY; Li B; Li SM
Int J Gynecol Cancer; 2018 May; 28(4):713-720. PubMed ID: 29461339
[TBL] [Abstract][Full Text] [Related]
7. Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report.
McBee WC; Brainard J; Sawady J; Rose PG
Gynecol Oncol; 2007 Apr; 105(1):244-7. PubMed ID: 17316775
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report.
Mukasa A; Yanagisawa S; Saito K; Tanaka S; Takai K; Shibahara J; Ikegami M; Nakao Y; Takeshita K; Matsutani M; Saito N
J Neurosurg Spine; 2017 Mar; 26(3):319-324. PubMed ID: 27911225
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic surgery combining chemotherapy for vaginal yolk-sac tumor: a case report.
Fang X; Du W; Wang Q; Zhao X
Eur J Gynaecol Oncol; 2015; 36(3):335-8. PubMed ID: 26189265
[TBL] [Abstract][Full Text] [Related]
10. Ovarian yolk sac tumour in a girl - case report.
Sharma C; Shah H; Sisodiya Shenoy N; Makhija D; Waghmare M
Dev Period Med; 2017; 21(2):101-103. PubMed ID: 28796980
[TBL] [Abstract][Full Text] [Related]
11. Primary endodermal sinus tumor of the omentum.
Park NH; Ryu SY; Park IA; Kang SB; Lee HP
Gynecol Oncol; 1999 Mar; 72(3):427-30. PubMed ID: 10053119
[TBL] [Abstract][Full Text] [Related]
12. Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Song L; Wei X; Wang D; Yang K; Qie M; Yin R; Li Q
Medicine (Baltimore); 2019 Apr; 98(15):e15144. PubMed ID: 30985686
[TBL] [Abstract][Full Text] [Related]
13. Ovarian yolk sac tumor associated with pregnancy: a case report and review of the literature.
Miyamoto M; Takano M; Goto T; Kato M; Sasaki N; Furuya K
Eur J Gynaecol Oncol; 2014; 35(6):738-40. PubMed ID: 25556285
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice.
Arjona-Sánchez Á; Durán M; Sánchez-Hidalgo JM; Rufian-Peña S
Surg Oncol; 2019 Dec; 31():14-15. PubMed ID: 31472328
[No Abstract] [Full Text] [Related]
15. Primary yolk sac tumor (endodermal sinus tumor) of the vulva: case report and review of the literature.
Basgul A; Gokaslan H; Kavak ZN; Eren FT; Bozkurt N
Eur J Gynaecol Oncol; 2006; 27(4):395-8. PubMed ID: 17009634
[TBL] [Abstract][Full Text] [Related]
16. Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma.
Wang Y; Zhou F; Qian Z; Qing J; Zhao M; Huang L
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S198-200. PubMed ID: 25518772
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
[TBL] [Abstract][Full Text] [Related]
18. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
[TBL] [Abstract][Full Text] [Related]
19. Ovarian endodermal sinus tumor in a 76-year-old woman.
Filiz G; Ozuysal S; Bilgin T
J Obstet Gynaecol Res; 2003 Oct; 29(5):309-11. PubMed ID: 14641700
[TBL] [Abstract][Full Text] [Related]
20. Sustainable complete remission in recurrence yolk sac tumor patient treated with tandem high-dose chemotherapy and autologous stem cell.
Abdullah NA; Wang PN; Huang KG; Adlan AS; Casanova J
Eur J Gynaecol Oncol; 2013; 34(2):183-5. PubMed ID: 23781595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
